Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts
Jeremiah Chakaya, Mishal Khan, Francine Ntoumi, et al.
International Journal of Infectious Diseases (2021) Vol. 113, pp. S7-S12
Open Access | Times Cited: 887

Showing 1-25 of 887 citing articles:

Cross Mark Policy

(2022)
Open Access | Times Cited: 1336
Treatment Strategy for Rifampin-Susceptible Tuberculosis
Nicholas I. Paton, C S G Cousins, Celina Suresh, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 10, pp. 873-887
Open Access | Times Cited: 90
COVID-19 and tuberculosis: the double whammy of respiratory pathogens
Mohd Shariq, Javaid Ahmad Sheikh, Neha Quadir, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210264-210264
Open Access | Times Cited: 75
Global, regional and national trends in tuberculosis incidence and main risk factors: a study using data from 2000 to 2021
Wentao Bai, Edward Kwabena Ameyaw
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 25
Global, regional, and national mortality of tuberculosis attributable to alcohol and tobacco from 1990 to 2019: A modelling study based on the Global Burden of Disease study 2019
Jinyi Wu, Yue Zhang, Kai Wang, et al.
Journal of Global Health (2024) Vol. 14
Open Access | Times Cited: 20
Harnessing miRNAs: A Novel Approach to Diagnosis and Treatment of Tuberculosis
Ahmed S. Doghish, Ahmed I. Abulsoud, Yara A. Nassar, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 1
Closed Access | Times Cited: 3
Ending tuberculosis in China: health system challenges
Qian Long, Lei Guo, Weixi Jiang, et al.
The Lancet Public Health (2021) Vol. 6, Iss. 12, pp. e948-e953
Open Access | Times Cited: 64
Molecular Methods for Pathogenic Bacteria Detection and Recent Advances in Wastewater Analysis
Shuxin Zhang, Xuan Li, Jiangping Wu, et al.
Water (2021) Vol. 13, Iss. 24, pp. 3551-3551
Open Access | Times Cited: 61
Exploiting genomics to mitigate the public health impact of antimicrobial resistance
Claire S. Waddington, Megan E. Carey, Christine J. Boinett, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Mycobacterium tuberculosis Protein PE6 (Rv0335c), a Novel TLR4 Agonist, Evokes an Inflammatory Response and Modulates the Cell Death Pathways in Macrophages to Enhance Intracellular Survival
Neha Sharma, Mohd Shariq, Neha Quadir, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 58
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies
Divya Tiwari, Adrian R. Martineau
Seminars in Immunology (2022) Vol. 65, pp. 101672-101672
Open Access | Times Cited: 56
Artificial Intelligence Techniques to Predict the Airway Disorders Illness: A Systematic Review
Apeksha Koul, Rajesh K. Bawa, Yogesh Kumar
Archives of Computational Methods in Engineering (2022) Vol. 30, Iss. 2, pp. 831-864
Open Access | Times Cited: 55
A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs)
Shefali Chowdhary, Shalini Shalini, Amandeep Arora, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 536-536
Open Access | Times Cited: 48
Machine learning analysis of SERS fingerprinting for the rapid determination of Mycobacterium tuberculosis infection and drug resistance
Liang Wang, Xue-Di Zhang, Jia-Wei Tang, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 5364-5377
Open Access | Times Cited: 44
Recent Progress on Bioinspired Antibacterial Surfaces for Biomedical Application
Xiao Yang, Wei Zhang, Xuezhi Qin, et al.
Biomimetics (2022) Vol. 7, Iss. 3, pp. 88-88
Open Access | Times Cited: 40
Mechanisms of isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: A review
Xiuping Zhuang, Li Li, Tianyi Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis
Yu Imai, Glenn Hauk, Jeffrey Quigley, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 11, pp. 1236-1244
Open Access | Times Cited: 39
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria
Kanwal Khalid, Chit Laa Poh
Vaccines (2023) Vol. 11, Iss. 7, pp. 1264-1264
Open Access | Times Cited: 39
Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis
Giuseppe Mancuso, Angelina Midiri, Silvia De Gaetano, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2277-2277
Open Access | Times Cited: 32
Immunological factors linked to geographical variation in vaccine responses
Marloes M.A.R. van Dorst, Jeremia J Pyuza, Gyaviira Nkurunungi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 250-263
Closed Access | Times Cited: 32
A terpene nucleoside from M. tuberculosis induces lysosomal lipid storage in foamy macrophages
Melissa Bedard, Sanne van der Niet, Elliott M. Bernard, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 28
The incidence rate of tuberculosis and its associated factors among HIV-positive persons in Sub-Saharan Africa: a systematic review and meta-analysis
Temesgen Gebeyehu Wondmeneh, Ayal Tsegaye Mekonnen
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Evolution of tuberculosis diagnostics: From molecular strategies to nanodiagnostics
Srestha Mukherjee, Summaya Perveen, Anjali Negi, et al.
Tuberculosis (2023) Vol. 140, pp. 102340-102340
Open Access | Times Cited: 23
Cytochrome bd oxidase: an emerging anti-tubercular drug target
Pallavi Saha, Samarpita Das, Harish K. Indurthi, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 769-787
Closed Access | Times Cited: 12
Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis
Shaban Ahmad, Akash Pratap Singh, Nagmi Bano, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132332-132332
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top